| Execution period | Financial Year 2026-27 |
|---|
NSE filing, NSE: INDUSINDBK. Summary written from the filing by ALFA Finder's alert engine.
IndusInd Bank Ltd: key numbers
- Share price
- ₹838.50
- Market cap
- ₹65,331 Cr
- Revenue (annual)
- ₹46,251 Cr
- Net profit (annual)
- ₹889.3 Cr
- P/E (TTM)
- 21.8×Sector 19.1×
- Promoter holding
- 15.82%+0.00% QoQ
- FII holding
- 30.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IndusInd Bank Ltd
All →IndusInd Bank Debt & Borrowing: ₹227.1 Cr
IndusInd Bank certified payment of Rs.227.08 crore interest on its Tier 2 Bonds (ISIN INE095A08090) on the due date of 29 October 2026. This is a Regulation 57 debt servicing confirmation.
- Value
- ₹227.1 Cr
IndusInd Bank Results Update
IndusInd Bank's Q2 FY27 press release reports net profit of ₹1,242 crore versus a prior-year loss. Gross NPA improved to 2.73% from 3.60%.
IndusInd Bank Investor Presentation: Key Takeaways
Q2FY27 PAT ₹1,242cr (+20% QoQ) and operating profit ₹2,874cr (+40% YoY), driven by loan growth and better asset quality. NIM fell to 3.23% from 3.57% QoQ. GNPA 2.73%, CRAR 16.59%.
IndusInd Bank Management Change
IndusInd Bank appointed Ms. Priyanka Sinha as Non-Executive Independent Director for four years from 23 Oct 2026, subject to shareholder approval. The filing is a Regulation 30 disclosure with her profile attached.
IndusInd Bank Q2 FY27 Results: Turns Profitable, Net Profit ₹1,242 Cr
IndusInd Bank Ltd reported revenue from operations of ₹11,796 Cr (+1.6% YoY) and net profit of ₹1,242 Cr for Q2 FY27.
- Key figure
- Net profit ₹1,242 Cr
IndusInd Bank Employee Stock Options
IndusInd Bank's Compensation Committee approved 1,00,000 stock options to 11 employees under its ESOP scheme. Grant price is Rs. 849.55 with 3-year vesting.
Other regulatory approval announcements
All →City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031
360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.